- Saudi Arabia
- /
- Food and Staples Retail
- /
- SASE:4163
Why Al-Dawaa Medical Services' (TADAWUL:4163) Earnings Are Better Than They Seem
Investors signalled that they were pleased with Al-Dawaa Medical Services Company's (TADAWUL:4163) most recent earnings report. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers.
Examining Cashflow Against Al-Dawaa Medical Services' Earnings
One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. The ratio shows us how much a company's profit exceeds its FCF.
Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
Al-Dawaa Medical Services has an accrual ratio of -0.12 for the year to December 2024. Therefore, its statutory earnings were quite a lot less than its free cashflow. Indeed, in the last twelve months it reported free cash flow of ر.س683m, well over the ر.س370.1m it reported in profit. Al-Dawaa Medical Services' free cash flow improved over the last year, which is generally good to see.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Al-Dawaa Medical Services' Profit Performance
As we discussed above, Al-Dawaa Medical Services has perfectly satisfactory free cash flow relative to profit. Because of this, we think Al-Dawaa Medical Services' earnings potential is at least as good as it seems, and maybe even better! And the EPS is up 55% annually, over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Al-Dawaa Medical Services, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 1 warning sign for Al-Dawaa Medical Services you should know about.
Today we've zoomed in on a single data point to better understand the nature of Al-Dawaa Medical Services' profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SASE:4163
Al-Dawaa Medical Services
Primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Micron Technology will experience a robust 16.5% revenue growth
Amazon will rebound as AI investments start paying off by late 2026

Inside Harvey Norman: Asset-Heavy Retail in an Online World
Popular Narratives

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
